Abstract:Down syndrome (DS) is the most common birth defect in children. To investigate the mechanisms of DS, the present study analyzed the bisulfite‑sequencing (seq) data GSE42144, which was downloaded from the Gene Expression Omnibus. GSE42144 included DNA methylation data of three DS samples and three control samples, and RNA‑seq data of two DS samples and five control samples. The methylated sites in the bisulfite‑seq data were detected using Bismark and Bowtie2. The BiSeq tool was applied to determine differentially methylated regions and to identify adjacent genes. Using the Database for Annotation, Visualization and Integrated Discovery, the functions of the abnormal demethylated genes were predicted by functional enrichment analyses. Differentially expressed genes (DEGs) were then screened using a paired t‑test. Furthermore, the interactions of the proteins encoded by selected genes were determined using the Search Tool for the Retrieval of Interacting Genes, and a protein‑protein interaction (PPI) network was constructed using Cytoscape. A total of 74 CpG regions showed significant differential DNA methylation between the DS and normal samples. There were five abnormal demethylated DNA regions in chromosome 21. In the DS samples, a total of 43 adjacent genes were identified with demethylation in their promoter regions and one adjacent gene was identified with upregulated methylation in its promoter regions. In addition, 584 upregulated genes were identified, including 24 genes with transcriptional regulatory function. In particular, upregulated Runt‑related transcription factor 1 (RUNX1) was located on chromosome 21. Functional enrichment analysis indicated that inhibitor of DNA binding 4 (ID4) was involved in neuronal differentiation and transcriptional suppression. In the PPI network, genes may be involved in DS by interacting with others, including nuclear receptor subfamily 4 group A member 2 (NR4A2)‑early growth response (EGR)2 and NR4A2‑EGR3. Therefore, RUNX1, NR4A2, EGR2, EGR3 and ID4 may be key genes associated with the pathogenesis of DS.

RUNX1 Upregulation Causes Mitochondrial Dysfunction Via Regulating the PI3K-Akt Pathway in Ipsc from Patients with Down Syndrome

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids

Abstract 12562: DYRK1A/PPARG/EGR1 Pathway Elicits Endothelial Dysfunctions and Predispose to Developing Pulmonary Hypertension in Down Syndrome

METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome

Large-scale RNAi Screen Identified Dhpr As a Regulator of Mitochondrial Morphology and Tissue Homeostasis

Realizing the Potential of Exploiting Human IPSCs and Their Derivatives in Research of Down Syndrome

Single-cell RNA Sequencing of Neural Stem Cells Derived from Human Trisomic Ipscs Reveals the Abnormalities During Neural Differentiation of Down Syndrome.

The Study of Alternative Splicing Events in Human Induced Pluripotent Stem Cells From a Down's Syndrome Patient

RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome

Novel Function of PITH Domain-Containing 1 As an Activator of Internal Ribosomal Entry Site to Enhance RUNX1 Expression and Promote Megakaryocyte Differentiation

Integrated Analysis of Dna Methylation and Rna-Sequencing Data in Down Syndrome

APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome

RUNX1 C-terminal Mutations Impair Blood Cell Differentiation by Perturbing Specific Enhancer-Promoter Networks

Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome

DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome

RUNX1 Deficiency Cooperates with SRSF2 Mutation to Further Disrupt RNA Splicing and Exacerbate Myelodysplastic Syndromes in Mouse Models

Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development

Reduced REST Expression in Neural Progenitor Cells, Adult Cortex, and Impaired REST Nuclear Translocation in the Prefrontal Cortex of Ts1Cje Mouse Model of Down Syndrome

Overexpression of PGC-1α Influences the Mitochondrial Unfolded Protein Response (mtupr) Induced by MPP+ in Human SH-SY5Y Neuroblastoma Cells